British tennis star provisionally suspended from all tournaments after failing drugs test

British tennis player Tara Moore has been provisionally suspended by the International Tennis Integrity Agency (ITIA) following a failed drugs test. The 29-year-old provided a sample which included substances on the World Anti-Doping Agency's (WADA) prohibited list.

Samples taken were split and analysis of Sample A found traces of Nandrolone metabolites and Boldenone. Both are on WADA's list of banned substances for 2022.

Moore has denied taking a banned and has said she is 'saddened' by her provisional suspension. She is ineligible to play in any official tournament but has the opportunity to request that Sample B is analysed to see if it matches Sample A.

An ITIA statement read: "The ITIA has confirmed that Tara Moore, a 29-year-old British tennis player, has been provisionally suspended under Articles 2.1 and 2.2 of the 2022 Tennis Anti-Doping Programme (TADP). The ITIA sent the player a pre-charge notice of an Anti-Doping Rule Violation on 27 May under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player's Sample) and Article 2.2 (Use of a Prohibited Substance without a valid TUE).

JUST IN: John McEnroe makes unusual Rafael Nadal promise after French Open win

"Ms Moore provided a sample whilst competing at a WTA tournament in Bogota, Colombia in April 2022. The sample was split into A and B samples and the subsequent analysis found that the A sample contained Nandrolone metabolites and Boldenone and its metabolite, which are prohibited substances listed in the 2022 World Anti-Doping Agency (WADA) Prohibited List. Adverse Analytic Findings for non-specified substances carry a mandatory provisional suspension.

"The player now has the opportunity to request that the B sample is analysed to see